Geneseeq is a research-driven company providing cutting-edge next-generation sequencing (NGS) technology to accelerate precision cancer care. We offer both pan-cancer panels analyzing 400+ genes and cancer-type specific gene panels for all sample types to help match a patient to the optimal treatment, including targeted therapy and immunotherapy. We have 1000+ research projects with biopharma and research partners, providing high-quality genomic data to accelerate translational research. Our headquarters are located in both Canada and China. Our CAP/CLIA accredited clinical laboratory is equipped with multiple advanced NGS sequencing platforms. We work closely with you to solve your specific needs, with a relentless focus on quality and efficiency. Let’s accelerate precision cancer care, together.
Location: China, Jiangsu, Nanjing City
Employees: 501-1000
Founded date: 2012
Investors 1
| Date | Name | Website |
| - | Cowin Capi... | cowincapit... |
Mentions in press and media 1
| Date | Title | Description | Source |
| 21.07.2017 | China: Geneseeq closes Series C led by Industrial Innovation... | Premium Geneseeq, a Nanjing and Toronto-based genetic sequencing venture founded in 2008, has secure... | dealstreet... |